Skip to content

Research at St Andrews

COVID-19 pandemic - A focused review for clinicians

Research output: Contribution to journalReview articlepeer-review

Author(s)

Muge Cevik, Connor Bamford, Antonia Ho

School/Research organisations

Abstract

BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019 and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice.

OBJECTIVES: Here we provide an update for clinicians on the recent developments about virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature.

SOURCES: We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects.

CONTENT: We describe the virological characteristics of SARS-CoV-2 and clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options.

IMPLICATIONS: The key challenge in managing COVID-19 remains the patient density. However, accurate diagnoses as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.

Close

Details

Original languageEnglish
JournalClinical Microbiology and Infection
VolumeIn press
Early online date25 Apr 2020
DOIs
Publication statusE-pub ahead of print - 25 Apr 2020

    Research areas

  • Coronavirus, COVID-19, Novel coronavirus, SARS-CoV-2

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Expect the unexpected – implications for next phase of COVID-19 response

    Clifford, S., Cevik, M., Campbell, R., O’Shea, D. & Sutherland, R., Jun 2021, In: Infection Prevention in Practice. 3, 2, 100118.

    Research output: Contribution to journalArticlepeer-review

  2. A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB

    Tweed, C. D., Wills, G. H., Crook, A. M., Amukoye, E., Balanag, V., Ban, A. Y. L., Bateson, A. L. C., Betteridge, M. C., Brumskine, W., Caoili, J., Chaisson, R. E., Cevik, M., Conradie, F., Dawson, R., del Parigi, A., Diacon, A., Everitt, D. E., Fabiane, S. M., Hunt, R., Ismail, A. I. & 19 others, Lalloo, U., Lombard, L., Louw, C., Malahleha, M., McHugh, T. D., Mendel, C. M., Mhimbira, F., Moodliar, R. N., Nduba, V., Nunn, A. J., Sabi, I., Sebe, M. A., Selepe, R. A. P., Staples, S., Swindells, S., van Niekerk, C. H., Variava, E., Spigelman, M. & Gillespie, S. H., 1 Apr 2021, In: International Journal of Tuberculosis and Lung Disease. 25, 4, p. 305-314 10 p.

    Research output: Contribution to journalArticlepeer-review

  3. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol

    Sigfrid, L., Cevik, M., Jesudason, E., Lim, W. S., Rello, J., Amuasi, J., Bozza, F., Palmieri, C., Munblit, D., Holter, J. C., Kildal, A. B., Reyes, L. F., Russell, C. D., Ho, A., Turtle, L., Drake, T. M., Beltrame, A., Hann, K., Bangura, I. R., Fowler, R. & 17 others, Lakoh, S., Berry, C., Lowe, D. J., McPeake, J., Hashmi, M., Dyrhol-Riise, A. M., Donohue, C., Plotkin, D., Hardwick, H., Elkheir, N., Lone, N. I., Docherty, A., Harrison, E., Baille, J. K., Carson, G., Semple, M. G. & Scott, J. T., Mar 2021, In: BMJ Open. 11, 3, 8 p., e043887.

    Research output: Contribution to journalArticlepeer-review

  4. COVID-19, children and schools: overlooked and at risk

    Munro, A., Bowen, A. C. & Cevik, M., 28 Feb 2021, In: Medical Journal of Australia. 214, 4, p. 188

    Research output: Contribution to journalLetter

  5. How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19

    Accorsi, E. K., Qiu, X., Rumpler, E., Kennedy-Shaffer, L., Kahn, R., Joshi, K., Goldstein, E., Stensrud, M. J., Niehus, R., Cevik, M. & Lipsitch, M., 25 Feb 2021, In: European Journal of Epidemiology. 18 p.

    Research output: Contribution to journalReview articlepeer-review

Related by journal

  1. Clinical Microbiology and Infection (Journal)

    Muge Cevik (Member of editorial board)

    2019 → …

    Activity: Publication peer-review and editorial work typesEditor of research journal

Related by journal

  1. Defining the role of asymptomatic and pre-symptomatic SARS-CoV-2 transmission - a living systematic review

    Qiu, X., Nergiz, A. I., Maraolo, A. E., Bogoch, I. I., Low, N. & Cevik, M., 20 Jan 2021, In: Clinical Microbiology and Infection. In press

    Research output: Contribution to journalArticlepeer-review

  2. Gender disparities in coronavirus disease 2019 clinical trial leadership

    Cevik, M., Haque, S. A., Manne-Goehler, J., Kuppalli, K., Sax, P. E., Majumder, M. S. & Orkin, C., 5 Jan 2021, In: Clinical Microbiology and Infection. In press

    Research output: Contribution to journalArticlepeer-review

  3. Submissions and publications in Corona times

    Leibovici, L., Allerberger, F., Cevik, M., Huttner, A., Paul, M., Rodríguez-Baño, J. & Scudeller, L., 15 May 2020, In: Clinical Microbiology and Infection. 26, 7, p. 803-804

    Research output: Contribution to journalEditorial

ID: 267728569

Top